Last reviewed · How we verify

sedative mixture

Helsinki University Central Hospital · FDA-approved active Small molecule

A sedative mixture that depresses the central nervous system to induce sedation and reduce anxiety.

A sedative mixture that depresses the central nervous system to induce sedation and reduce anxiety. Used for Sedation in clinical settings, Anxiety management.

At a glance

Generic namesedative mixture
Also known as-Ultiva, -Diprivan
SponsorHelsinki University Central Hospital
Drug classSedative/Hypnotic combination
ModalitySmall molecule
Therapeutic areaNeurology/Anesthesia
PhaseFDA-approved

Mechanism of action

Sedative mixtures typically combine multiple CNS depressants (such as benzodiazepines, barbiturates, or other hypnotics) to achieve enhanced sedative effects through synergistic action on GABAergic and other inhibitory neurotransmitter pathways. The specific composition and mechanism depend on the individual components of the mixture formulated by Helsinki University Central Hospital.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results